Anticoagulation in COVID-19. | Lancet;399(10319): 5-7, 2022 01 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Anticoagulation in COVID-19.

Bradbury, Charlotte A; McQuilten, Zoe.

Bradbury CA; Bristol Haematology and Oncology Centre, University of Bristol, Bristol BS2 8ED, UK. Electronic address: c.bradbury@bristol.ac.uk.
McQuilten Z; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Clinical Haematology, Monash Health, Melbourne, VIC, Australia.

Lancet ; 399(10319): 5-7, 2022 01 01.

Article in English | MEDLINE | ID: covidwho-1623430

Subject(s)

COVID-19; Anticoagulants/adverse effects; Blood Coagulation/drug effects; Humans; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Limits: Humans Language: English Journal: Lancet Year: 2022 Document Type: Article